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ABSTRACT  Studies  on the origin, identification,  and characterization of osteoclasts have been 
difficult.  This is in part due to a lack of definitive  osteoclast markers and the similarity of these 
cells in  form  and  function  to  cells of the  mononuclear  phagocyte  system. To  solve this 
problem,  we  inoculated  isolated chick  osteoclasts into mice to generate osteoclast-specific 
monoclonal  antibodies.  Supernatants from  growth-positive  hybridomas  were  screened by 
indirect  immunofluorescent  methods against cultured  osteoclasts, monocyte-derived  multin- 
ucleated giant cells, cultured  monocytes, fibroblasts, and limb mesenchyme. Select hybrido- 
mas were cloned to produce 375 clones, which were analyzed as described above. Antibody 
from  select clones was also reacted with  paraffin sections of bone. In addition,  two clones 
have  been analyzed  by  enzyme-linked  immunosorbent  asssay (ELISA) and  Western blot 
analysis. Antibody binding from an osteoclast-specific clone and a clone reactive with osteo- 
clasts, giant cells, and cultured  monocytes (as determined  by immunohistochemical  assay) 
was  confirmed  by antibody-binding and titration  curves quantitated  by  ELISA. The above 
studies demonstrate that osteoclast specific antigens exist, and that osteoclasts, giant cells, 
and cultured  monocytes share common determinants not found on other cells screened. 
The multinucleated osteoclast serves as the major cell type 
responsible for degradation of bone matrix, and its impor- 
tance in  bone growth,  skeletal remodeling, and  electrolyte 
homeostasis has been well established (1-3). The mechanisms 
and regulation of osteoclast-mediated bone resorption are not 
yet clearly understood; moreover, little is known about the 
recruitment and differentiation of osteoclast precursors (4, 5). 
It is generally believed that osteoclasts originate from cells 
belonging to the mononuclear phagocyte system (6-8). Al- 
though different, macrophages and osteoclasts share certain 
similarities in form and function, including membrane folding 
(9), positive acid phosphatase staining, activity of other lyso- 
somal enzymes, and the ability to degrade connective tissue 
(2,  10). Chick-quail chimera studies (l l,  12) have demon- 
strated a blood-borne origin for the osteoclast, and parabiosis 
and marrow transplantation have been successfully  used to 
correct the  osteoclast defect in  osteopetrosis (13,  14). To- 
gether, these observations support the hypothesis that osteo- 
clasts are polykaryons that derive from circulating mononu- 
clear cells belonging to the monocyte-macrophage family. 
In various cell populations, a seemingly homogeneous phe- 
notype can now be divided into functional subpopulations 
with  monoclonal antibodies  raised  to  unique  cell  surface 
components. In this  regard,  mononuclear phagocytes have 
been shown to play important roles as antigen-presenting cells 
(15),  cytotoxic effector cells (16),  and also as secretory cells 
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(17). Recently, it has been demonstrated by the use of mono- 
clonal antibody technology that  one cell  type may not be 
responsible for all functions. In this context, Sun and Loh- 
mann-Matthes (18) employed monoclonal antibodies to iden- 
tify functional subpopulations of macrophages. One popula- 
tion was responsible for natural killer activity, one for lym- 
phokine-induced macrophage cytotoxicity, and one for nei- 
ther function. Raffe et al. (19) described a monoclonal anti- 
body  reactive  specifically  with  antigen-presenting  macro- 
phages.  Therefore, if osteoclasts were a specialized subpopu- 
lation of macrophages, they would share some surface anti- 
gens with macrophages but possess a unique set of osteoclast 
specific cell surface components. However, to date no distin- 
guishing markers have been identified. 
A concern of many workers who deal with osteoclast de- 
velopment and function is  related to the definition of the 
osteoclast.  This  results,  in  part,  from  a  lack  of definitive 
phenotypic markers for this cell as well as its similarity to 
other cells of the mononuclear phagocyte series. Populations 
of osteoclasts have been relatively inaccessible for study, and 
in vitro macrophage systems have been employed as surro- 
gates to identify factors that are involved in osteoclast activity 
(20, 21). Recently, we developed an osteoclast isolation pro- 
cedure that permits investigation of the osteoclast in  vitro 
(22). In addition, we have described a cell culture system in 
which peripheral blood monocytes, when cultured under high 
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(MNGC). ~ The MNGC,  although  in  some ways similar to 
cultured osteoclasts, differ in cell surface appearance and in 
ultrastructure. As a consequence, we have postulated that they 
are  closely related  to  osteoclasts,  but  represent  a  different 
phenotype. 
In this report, we describe results obtained using osteoclast 
isolated to produce osteoclast-specific monoclonal antibodies. 
In these studies, antibodies produced by select hybridomas 
show  a  variable spectrum of cell  reactivity when  screened 
against osteoclasts, monocyte-derived MNGC, macrophages, 
monocytes, and other phenotypes. From the results, it appears 
that monoclonal antibodies can be used to recognize osteo- 
clast-specific cell surface antigens, and, furthermore, that os- 
teoclasts, MNGC, and monocyte-derived macrophages share 
common antigenic determinants. 
MATERIALS  AND  METHODS 
Osteoclast Isolation and Mouse Immunization:  Osteoclasts 
were isolated using a modification  of the method of Osdoby et al. (22). White 
leghorn chick hatchlings were fed a low calcium diet (Purina) for at least l0 d 
to elevate osteoclast number (23). Chicks were killed and tibias dissected free 
of surrounding muscle and connective tissue. Bones were placed in Tyrode's 
balanced salt solution,  pH 7.4, split, and the marrow removed.  Marrow free 
bones were rinsed in a Ca-Mg free Tyrode's and subsequently incubated in Ca- 
Mg free Tyrode's containing  0.5% trypsin  (Worthington  Biochemical Corp., 
Freehold, N  J) and 0.03% EDTA for 30 min at 37"C. Bones were then agitated 
gently to remove loosely adherent  cells, they were transferred to fresh trypsin 
solution for an additional  15 min at 37"C, and the trypsin action stopped with 
two washes of Ca-Mg free Tyrode's containing 5% fetal calf serum. Thereafter, 
tibias were incubated  in 0.1% neutral  red  prepared  in Tyrode's  to visualize 
osteoclasts on bone. After several rinses with Tyrode's, osteoclasts were detached 
from bones by Ca-Mg Tyrode's  buffer streaming,  and the cells suspended in 
minimal essential medium containing  15% fetal calf serum. 
Cell suspensions were pelleted at 400 g for 5 rain and resuspended in 50% 
Percoll (Pharmacia Fine Chemicals, Piseataway, N  J) prepared with Ca-Mg free 
Tyrode's. 40, 30, 20, and 10% Pereoll fractions were sequentiaUy overlayed on 
the 50%  Percoll solution,  and the gradients centrifuged in an HB-4 swinging 
bucket rotor at 400 g for 20 rain at 22"C. The top layers containing osteoclasts 
and a population  of mononuclear cells were harvested and rinsed in Ca-Mg- 
free Tyrode's. Cell suspensions were passed through 10-urn mesh nylon screens 
that  allowed  the  passage of small  cells while  retaining  osteoclasts  on  the 
membrane. The nylon screens were then backwashed with minimal essential 
medium +  15% fetal calf serum and 70-90%  enriched osteoclast cell popula- 
tions were obtained. 
Osteoclasts were placed in fresh minimal essential medium +  15% fetal calf 
serum and allowed to recover for 30 min before inoculating  into mice. Ap- 
proximately  2 x  l06 osteoclasts per 0.1  ml of Tyrode's were injected into the 
retro-ocular sinus per mouse. This protocol was repeated every 2 wk until high 
antibody  titers were achieved. Mice were then inoculated  once more and 3 d 
later they were killed and their spleens harvested. 
Fusion and Hybridoma  Production:  Spleen cells from immu- 
nized mice were fused with myeloma cells by the method of Galfre et al. (24). 
50% polyethylene glycol 1500 (Fisher Scientific Co., Pittsburgh, PA) was used 
to  fuse 2  x  l08  spleen cells with  2  x  l07  myeloma  cells (25). Cells were 
transferred  to  96-well tissue  culture  plates  and  maintained  in  Dulbecco's 
modified Eagle's medium containing  5% calf serum, 10% horse serum, 2% a- 
glutamine,  1 mM  sodium pyruvate,  and  1%  antibiotic-antimycotic  (Gibco 
Laboratories, Grand Island, NY) (CM medium). Cells were grown at 37"C in 
92%  air,  8%  CO2. After  24  h,  the  medium was changed  to CM  medium 
containing  hypoxanthine,  aminopterin,  and thymidine.  Medium was changed 
every third day until cells became confluent. 
Initial I-lybridoma  Screening:  Hybridoma growth-positive  wells 
were screened to determine  antibody  specificity for osteoclasts. Isolated osteo- 
clasts were inoculated  into 24-well culture  dishes containing  9-mm collagen 
coated coverslips and cell attachment  was evident after 4 h at 37"C. Coverslips 
were then rinsed in Tyrode's balanced salt solution,  pH 7.4, and fixed in  1% 
formaldehyde  in phosphate-buffered  saline, pH 7.4 (PBS). Hybridoma tissue 
J  Abbreviations  used  in  this paper.  ELISA,  enzyme-linked immu- 
nosorbent assay; MNGC, multinucleated giant cells;  UV, ultraviolet. 
culture  supernatants were then reacted  with  the cells for  l  h  at  22°C, the 
coverslips were rinsed  in PBS and reacted  with  fluorescein-conjugated  anti- 
mouse IgG (Cappel Laboratories, Cochranville, PA) for l h at 22°C, and rinsed 
and mounted on slides. Positive and negative controls were used throughout 
all screening assays. 
Hybridoma  supernatants  testing  positive  for  osteoclasts  were  screened 
against day-6 cultured  limb mesenchymal cells (26), monocytes cultured  for 2 
d, and monocylc-derived MNGC (22). In some cases hybridoma supernatants 
were screened against skin  fibroblasts (27). All cell types were grown on or 
transferred to coverslips, allowed to attach for 4 h, and fixed and processed for 
antibody staining as already described. 
Tissue Section  Screening:  Clonal tissue culture supernatants were 
concentrated by lyophilization to one-eighth their original volume and dialyzed 
against  PBS. Paraffin  sections  of chick  bone,  liver, and  whole  10-d chick 
embryos were prepared  by the method of Saint-Marie  (28), and fluorescent 
antibody  staining was done as previously described. All clonal tissue culture 
supernatants  were tested singly and, in some cases, in combination. 
Production  of Ascitic Fluid:  BALB/c mice were primed by intra- 
peritoneal  injection  of 0.5  ml of pristane  (2,6,10,14-tetramethylpentadecane) 
and two weeks later 2-5 x  l06 hybrid cells from select clones were slmilarily 
injected. 7-14 d thereafter ascitic fluid was collected and centrifuged at 250 g 
for l0 min to remove cells and debris. Aliquots of aseites were snap frozen in 
liquid nitrogen and stored at -20°C until used. 
Enzyme-linked Immunosorbent Assay:  Ascites from two rep- 
resentative  clones  were analyzed  by enzyme-linked  immunoassay (ELISA). 
Cells were obtained  as already described, spun down onto microtiter  plates 
pretreated  with  poly-L-lysine, and  fixed with  1%  formaldehyde  and 0.01% 
glutaraldehyde  in PBS. After blocking with  1%  BSA-10%  horse serum,  the 
cells were reacted with dilutions  of ascites prepared  in  1.0% BSA-10% horse 
serum in PBS for l h at 37°C. After a buffer wash, peroxidase-labeled affinity 
purified rabbit-anti-mouse  IgG, prepared in 0.67% BSA-PBS, was added to all 
samples and allowed to react for l h at 37°C. Following several washings, the 
substrate ABTS (2,2-azinondi-C3-ethyl-benzthiazoline sulfonate) in eacodylate 
buffer containing  hydrogen peroxide was added to all samples. After  l h, the 
product formed was read at an absorption of 405 mm with a Dynatech ELISA 
reader (29). The absorbance  reading was normalized  against protein  present 
(30). Similarily cell number was varied with a constant aseites concentration. 
Western  Blot  Analysis:  Whole  cell homogenates  of  osteoclasts, 
MNGC,  (10  x  l06  cells) cultured  monocytes,  (25  x  106  cells), and  limb 
mesenchyme (25 x  l0  ~  cells) were electrophoresed on 10% SDS polyacrylamide 
gels (3 l) and transferred  to nitrocellulose using a Hoefer electrotransfer  unit 
(Hoefer Scientific Instruments, San Francisco, CA). The method of Burnette 
(32) was used to transfer and visualize antigenic components  to 121F antibody. 
RESULTS 
Cell Isolation and Culture 
The procedure for osteoclast isolation used in these studies 
yields cell preparations enriched 70-90% for the bone resorb- 
ing cells. Typically 1 x  l06 osteoclasts are obtained from each 
bird, routinely  107 osteoclasts are harvested per preparation 
and  ~75%  of isolated  osteoclasts attach  to  culture  dishes 
within 4 h after inoculation. The cells flatten out on culture 
dishes, remain multinucleated, exhibit multiple microtubular 
organizing centers (not shown), and display a plasma mem- 
brane profile with numerous processes and microvilli project- 
ing from the surface (Fig.  1A). Osteoclasts cultured on colla- 
gen-coated surfaces do not spread out but maintain a rounded 
configuration comparable to that observed on the bone sur- 
face (Fig. 2A). Aside from cell shape, these cells are essentially 
identical morphologically to those cultured in the absence of 
collagen. 
Peripheral blood monocytes isolated by Ficoll-hypaque sep- 
aration  techniques  and  seeded at high  initial  cell  densities 
attach to culture dishes within 24 h. These cells fuse in culture 
and by day 6 MNGC predominate (Fig.  1  B). Although pos- 
sessing  multiple  nuclei,  these  cells  lack  the  ultrastructural 
complexity of isolated cultured osteoclasts (22). For example, 
MNGC have fewer mitochondria and polysomes, and, when 
grown  under  identical  culture  conditions  to  osteoclasts, 
OURSI-ER  ET  AL.  Osteoclast-specific  MonoclonalAntibodies  1593 FIGURE  1  (a) Scanning electron micrograph  of isolated osteoclast cultured for 6 d on tissue culture plate, Note small microvilli 
projecting up from cell surface and  numerous  processes radiating off the plasma membrane,  x  1,000, (b) Scanning electron 
micrograph  of monocyte-derived MNGC cultured for 6 d under same condilions of cell in a. Note membrane ruffling but fewer 
membrane processes and microvilli in comparison to cultured osteoctast, x  1,350. (Scanning electron micrographs prepared as 
outlined in reference 29,) 
MNGC  do  not  exhibit  the  numerous  microvilli  and  cell 
processes that are found on the cell surface of cultured osteo- 
clasts. 
Hybridoma Clonal Analysis 
Select hybridomas from fusion  1 were cloned, generating 
108 clones, similarly 267 clones were derived from fusion 2. 
Fig.  2, A and B, are photomicrographs of osteoclasts grown 
on collagen-coated coverslips and reacted with antibody pro- 
duced by clone 121F. Fig. 2B is the same field as Fig. 2A but 
viewed with  ultraviolet (UV) illumination to detect fluores- 
cent antibody. Osteoclasts exhibit intense fluorescence while 
the small cells  and matrix display background fluorescence. 
Likewise, flattened osteoclasts not  grown  on  collagen  stain 
positive with antibody, although the antibody localization is 
not evenly distributed over the cell surface (Fig. 2, C and D). 
Of the 375 clones that were produced and tested, 30 clones 
from 21  primary hybridomas elaborated  osteoclast-specific 
antibodies (including clone  121F),  and  l0 additional clones 
produced antibody reactive with osteoclast and MNGC only. 
l 0 other antibody-producing clones reacted with MNGC and 
cultured monocytes only, whereas antibody from five other 
clones  were  reactive with  osteoctast  MNGC,  and  cultured 
monocytes (including clone 29C). It was possible that primary 
clones are  not  true  clonal  populations but rather heteroge- 
neous hybridoma populations producing more than one an- 
tibody  species.  Such  a  possibility  could  account  for  cross 
reactivity between phenotypes. However, recloning of these 
primary clones have not altered their cell reactivity pattern. 
Tissue Section Screening 
Antibody from 107 clones were reacted with paraffin sec- 
tions  prepared  from  low  calcium  chick  bones.  37  clones 
produced antibody that reacted only with osteoclasts and gave 
fluorescent staining intensity comparable to that observed in 
isolated cells.  This specificity was determined by examining 
the  endosteal  surface  of bones with  intact  marrow cavities 
(Fig.  3, A and B) or the periosteal surface where osteoclasts 
and  periosteal fibroblasts are present (Fig.  3,  C  and  D).  In 
both  cases,  the  fluorescent  pattern  in  tissue  sections  was 
localized to osteoclasts when antibody from clone  121F was 
used. Rarely, a few mononucleated or binucleated cells in the 
marrow demonstrated weak  fluorescence.  These cells were 
usually closely associated with osteoclasts. Moreover, in areas 
of cartilage hypertrophy and resorption muitinucleated cells 
(chondroclasts) displayed positive fluorescent antibody bind- 
ing with antibody from clone  121F  (Fig.  4, A and B).  The 
cartilage ceils and matrix exhibited no antibody reactivity and 
in other sections not shown peripheral muscle tissue around 
bone was also nonreactive with 121F antibody. 
An additional set of clones demonstrated antibody reactiv- 
ity that was specifc for osteoclasts but exhibited weak fluo- 
rescence. 32 clones displayed antibody binding to osteoclasts 
and foci of marrow cells (Fig. 4, C and D) and an additional 
14 clones were nonspecific. In osteoclast-specific clones tested 
against liver sections there was no reactivity evident and in 
whole embryos displaying a wide spectrum of tissue types the 
only reactivity of 121 antibody was associated with osteoclasts 
in bone. 
ELISA 
To corroborate the immunohistochemical observations on 
antibody  specificity  and  cell  reactivity  antibody  dilution 
curves  were  generated  using  a  more  sensitive  peroxidase 
ELISA. Two antibody-producing clones were used in  these 
studies:  an  osteoclast-specific  clone,  121F9,  and  a  clone- 
producing  antibody  29C,  that  is  reactive  with  osteoclast, 
MNGC, and cultured monocytes. Fig.  5A  illustrates the re- 
sults of the antibody dilution curve for clone 121F9. It is clear 
that  with  increasing  concentrations  of ascites  from  12 IF9 
there is a concomitant increase in antibody binding to osteo- 
clasts.  However, saturation levels were not obtained at these 
1 594  THE JOURNAL OF  CELL BIOLOGY - VOLUME 100, 1985 FfGURE  2  (a)  Phase-contrast photomicrograph of osteoclasts and smaller cells plus  matrix debris (arrows) grown on  collagen- 
coated coverslips and reacted with 121F antibody followed by fluoresceinated anti-mouse IgG. Note elongated osteoclast. Small 
cells are intact or represent fragments of damaged osteoclasts, x  273. (b) Same field as a viewed by UV illumination to illustrate 
fluorescent staining on osteoclasts and a few smaller cells or fragments. Most small cells are negative for antibody binding, x  273. 
(c) Osteoclast grown on glass coverslip without collagen to illustrate flattened morphology and multinucleation, x  273. (d) Same 
field as c visualized by UV illumination to detect antibody binding unevenly distributed on cell surface (arrows). x  273. 
concentrations. It is also apparent that day-2 cultured mono- 
cytes and limb mesenchymal cells exhibit low level binding 
at all concentrations of ascites--levels representative of non- 
specificity. The MNGC antibody-binding curve shows a pat- 
tern similar to that observed with other nonosteoclastic cells. 
However, there is a slight increase in binding at the  1:4,000 
ascitic dilution.  The significance of this observation remains 
to be established. 
The dilution curve for antibody produced by clone 29C is 
depicted in Fig. 5 B. ELISA confirms the immunohistochem- 
OURSLER EX AL.  Osteoclast-specific  MonoclonalAntibodies  1595 FIGURE  3  Phase-contrast  photomicrograph of section from  low calcium chick tibia illustrating osteoclasts  (arrows)  on  body 
trabecula surrounded by marrow cells, x  420. (b) Same field as a viewed with UV illumination to illustrate fluorescent pattern of 
121F antibody binding to osteoclasts on body trabeculae and on tissue pulled away from bone surface, x  420. (c) Phase-contrast 
photomicrograph of section from  low calcium chick tibia in  the periosteal region. One prominent multinucleated osteoclast 
(arrow) is evident, x  420. (d) Same field as c viewed by UV illumination to illustrate antibody binding to osteoclasts from antibody 
testing osteoclast specific in cell analysis. Note negative image of nuclei in this micrograph and in b. x  420. 
ical observations. Antibody binding to osteoclasts and MNGC 
increase  with  increasing concentration  of ascites.  Like the 
immunohistochemical results, monocytes maintained in cul- 
ture show an increase in  antibody binding but the binding 
levels are greatly reduced.  Limb mesenchymal cells do not 
bind antibody from clone 29C. 
In experiments in which cell number was varied, the 121F 
antibody exhibited increased binding with increase in osteo- 
clast number. Minor elevation in antibody binding was de- 
tectable when other cell types were tested (Fig. 5 C). The 29C 
1596  THE  JOURNAL Of  CELL BIOLOGY • VOLUME  100,  1985 FIGURE  4  (a) Phase-contrast photomicrograph of tibia section from chick maintained on low calcium diet. Area of photomicro- 
graph illustrates region of cartilage erosion by chondroclasts (arrows). Note multinucleated cell not attached to matrix (arrow). x 
395. (b) Same field as a viewed by UV illumination to reveal fluorescent pattern of 121F antibody binding to chondroclasts and 
multinucleated cell not associated with matrix, x  395. (c) Phase-contrast photomicrograph of tibia section from chick maintained 
on low calcium diet. Bone surface is at the left and marrow makes up most of the field, x  490. (d) Same field as c viewed by UV 
illumination to reveal fluorescent pattern of 29C antibody binding to osteoclasts (arrows) and foci of marrow cells, x  490. 
antibody binding to cells rose relative to increases in osteoclast 
and MNGC number. However, no binding was detectable on 
cultured monocytes or limb mesenchyrne at the ascites con- 
centration used (1:8,000)  (Fig. 5 D). 
Western Blot Analysis 
Whole cell homogenates electrophoresed on 10% SDS poly- 
acrylamide gels, transferred to nitrocellulose,  and reacted with 
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FIGURE  5  (A)  Ascites  dilution curve for ascites produced from  121F9 hybridoma. The cell number was constant, i.e., 25,000, 
and the ascites concentration was changed. Broken line represents values of osteoclasts, double line represents values for MNGC, 
solid line represents  cultured monocytes, and dotted line represents  values obtained with cultured limb mesenchyme. Data is 
represented as absorbance per milligram protein and bars represent standard  deviation. (B) Ascites  dilution curve for ascites 
produced from 29C hybridoma. (C) Ascites concentration was kept constant and cell number varied for analysis of 121 F antibody 
binding. Data indicate correlation with increase in cell number and 121 F9 antibody binding to osteodasts. (D) Cell number varies 
for analysis of 29C antibody binding. Osteoclast and MNGC binding increased with increase in cell number. 
121F antibody reveal results consistent with the immunohis- 
tochemical cell screening and ELISA data. The osteoclast lane 
displays antibody recognition of antigen possessing apparent 
molecular weights of 96,000,  91,000,  and 45,000.  The rela- 
tionship of these components has yet to be determined. No 
antigen was recognized in the MNGC, cultured monocytes, 
or  mesenchymal  cell  lanes  (Fig.  6),  although  the  protein 
staining pattern  showed much more protein in  these lanes 
compared to the osteoclasts (not shown). 
DISCUSSION 
In this report we detail the results of experiments with osteo- 
clast-specific monoclonal antibodies that were generated in 
response to chick osteoclasts as immunogen. Immunohisto- 
chemical methods and ELISA have been successfully used to 
identify  hybridomas  producing  antibodies  to  osteoclasts. 
Moreover, cell and tissue screening protocols have enabled us 
to  select and  identify antibody-producing hybridomas that 
synthesize antibody to osteoclast antigens not detectable on 
the closely related monocyte, macrophage, MNGC, or mar- 
row cell.  Other  hybridomas derived from the  same spleen 
population have been shown to produce antibody cross-reac- 
tive with osteoclasts, MNGC, and cultured monocytes. These 
same antibodies  react with  osteoclasts and  foci of marrow 
cells in bone sections while those antibodies specific for osteo- 
clasts in cell isolates only recognize osteoclasts in tissue sec- 
tions. 
Western blot analysis has successfully identified the anti- 
genic determinant to clone  12 IF. The Western blot pattern 
includes a  45,000-mol-wt component. However, in prelimi- 
nary studies using immunoaffinity chromatography to purify 
121F antigen, no 45,000-mol-wt species is found. Therefore, 
this component may represent a breakdown product from the 
96,000- or 91,000-mol-wt species. 
In the tissue sections of bone, antibody binding did  not 
appear to be restricted to the cell surface but localized through- 
out the cell.  Two explanations can account for this staining 
pattern. First, the antigenic component may be on the surface 
but not restricted to the membrane. Second, and in a related 
fashion, it is known that the osteoclast membrane involutes 
deep into the cytoplasm, and such membrane folding may 
account for the apparent cytoplasmic localization. 
I  598  THE  JOURNAL  OF  CELL BIOLOGY • VOLUME  100,  1985 FIGURE 6  Western  blot  pattern  of  10%  SDS  polyacrylamide gel 
transferred  to nitrocellulose and reacted  with 121 F9 antibody and 
iodinated anti-mouse IgG. (Lane A) Molecular weight markers; (lane 
B) osteoclast  homogenates;  (lane C) MNGC homogenates;  (lane D) 
monocyte homogenates;  and (lane  E) mesenchymal  cell homoge- 
nates. 
The  localization  of osteoclast-specific antibodies  in  bone 
sections was occasionally found to include a few mononuclear 
cells.  These mononuclear cells have yet to be identified, but 
these cells may represent mononuclear osteoclasts, osteoclast 
progenitors, or even osteoclast fission products. In a number 
of reports, in which monoclonal antibodies have been raised 
to specific phenotypes, it has been found that the antibodies 
also recognize the immediate precursor population. This was 
shown to be the case for B-lymphocyte monoclonal antibodies 
(33). 
These observations demonstrate that monoclonal antibod- 
ies to cell surface components can be used to identify osteo- 
clasts.  These cell surface markers can likewise serve as pow- 
erful tools to discriminate osteoclasts from other giant cells 
and mononuclear phagocytes and quantitate osteoclast num- 
bers in bone. Perhaps as important, the pattern of hybridoma 
and clonal antibody reactivity to the phenotypes tested sug- 
gests that osteoclasts, MNGC, and monocyte-derived macro- 
phages share antigenic determinants not found on other cells 
screened. Such results support the hypothesis that osteoclasts, 
macrophages, and monocytes are in some way related. The 
osteoclast-specific and the phenotypic cross-reactive antibod- 
ies should prove to be valuable to help clarify the functional 
and developmental relationship between osteoclasts and other 
cells of the mononuclear phagocyte family. 
Haythorn (34) suggested that osteoclasts were members of 
a  family  of MNGC  found  throughout  many  organs.  He 
further suggested that the unique phenotypic features of the 
different multinucleated  cells was dependent  on local envi- 
ronmental factors affecting these cells.  This concept is con- 
sistent with our present understanding of tissue macrophage 
heterogeneity (18,  19). Therefore, it is quite possible that the 
bone environment in  some way imparts the unique pheno- 
typic qualities associated with osteoclasts. 
The  bone  environment  is  a  complex  milieu  known  to 
contain growth factors, and bioactive matrix components that 
individually or together help regulate fracture repair and bone 
remodeling (35).  Components of bone have been shown to 
influence  osteoclast precursor  recruitment  (36),  but  less  is 
known  in  regard  to  how the  bone environment influences 
osteoclast cytodifferentiation. The antibodies described in this 
report  should  now  make  it  possible  to  more  competently 
examine how specific components of  the osseous environment 
influence osteoclast development. 
Monoclonal antibody technology has been successfully used 
to  identify phenotypes and  discriminate  subpopulations of 
closely related  cell  populations  that  it  was  not  possible to 
segregate before. We have applied this technology to demon- 
strate  that  osteoclasts in  all  likelihood  represent  a  unique 
MNGC  that  can  be  discriminated  from other cells  of the 
mononuclear phagocyte system. 
We are grateful to Fred Anderson and Robin Bueler for their expert 
technical assistance and to Dr. Marilyn Krukowski for her construc- 
tive critique of this manuscript. We also acknowledge Dr. Dennis 
Flaherty and  Ms.  Peggy Winzenburger for their  help with ELISA 
assays. 
This work was supported by a grant from the Kroc Foundation, 
the Washington University School of Dental Medicine, and an Ar- 
thritis Foundation Investigator Award to Philip Osdoby. 
Received  for publication 21 May 1984, and in revised  form 21 January 
1985. 
REFERENCES 
1.  Chambers,  T.  1980.  The  cellular  basis of bone  resorption.  Clin.  Orthop.  Relat.  Res. 
151:283-293. 
2.  Vaes, G. 1980, Collagenase.  lysosomes,  and osteoclastic  bone resorption. In Collagenase 
in Normal and Pathological Connective Tissue. D. E. Woolly and J. M. Evanson, editors. 
John Wiley & Sons, New York. 185-207. 
3.  Baron, R., and A. Vigney. 1981. Behavior of osteoclasts  during a rapid change in their 
number  induced  by high doses of parathyroid  hormone of calcitonin  in  intact  rats. 
Metab.  Bone Dis. Relat.  Res. 2:339-346. 
4.  Marks, S.  1983, The origin of osteoclasts.  Z  Oral. Pathol.  12:226-256. 
5.  Kahn, A., D. Simmons, and M. KnJkowski. 1981. Osteoclast precursor cells are present 
in the blood  of preossification chick embryos. Dev. Biol.  84:230-234. 
6.  Walker,  D.  1975. Bone  resorption  restored  in  osteopetrotic  mice by transplants  of 
normal bone marrow and spleen cells. Science  (Wash, DC).  190:784-785. 
7.  Fisch  man, D. A., and E. D. Hay. 1962. Origin of osteoclasts  for mononuclear leucocytes 
in regenerating new limbs. Anat.  Rec.  143:329-338. 
8.  Jee, W. S., and P. D. Nolan.  1963. Origin of osteoclasts  from the fusion of phagocytes. 
Nature (Lond.).  200:225-226. 
9.  Gothlin,  G.,  and  J.  L.  E.  Ericsson.  1976. The  osteoclast.  Clin.  Orthop.  Relat.  Res. 
120:201-231. 
10.  Mundy, G., M. Airman, M. Gouder, and J. Bundelin.  1972. Direct resorption of bone 
by human monocytes. Science (Wash. DC).  196:1109-1111. 
1 I. Jotereau,  F., and N. LeDouarin.  1978. The developmental relationship between osteo- 
cyles  and  osteoclasts.  A  study  using quail-chick  nuclear  markers  in  endochondral 
ossification.  Dev. Biol. 63:253-265. 
IZ  Kahn, A., and D. Simmons. 1975. Investigation of cell lineage in bone using a chimaera 
of chick and quail embryonic tissue.  Nature (Lond.).  258:325-327, 
13.  Walker, D.  1975. Control  of bone resorption  by hematopoietic tissue. The induction 
OURSLER  lET  AL,  Osteoclast-specific  MonoclonalAntibodies  1599 and reversal of  congenital  osteopetrosis  in mice throug/t use of bone marrow and splenic 
transplants,  Z Exp. Med. 142:651-663, 
14  Coccia,  P.,  W.  Kriost,  J. Cervenka, C.  Clawson,  J  Kerry, T. Kim, M.  Nesbit,  N. 
Ramsay, P. Warkenton, S. Teitelbaum, A. Kahn, and D  B~own. 1980. Successful bone 
marrow transplantation for infantile  malignant osteopetrosis.  N, Engl. Z Meal 302:701- 
708. 
15.  Herberman, R.,  M.  Nunn, and H. Holden.  1978. Low density of THYI antigen on 
mouse effector  cells  mediating natural cytotoxicity  against tumor cells. J. lmmunol. 
121:304-309. 
16.  Lohmann-Matthes, M., F. Zeigler, and H. Fisher.  1973. Macruphage cytotoxicity  factor. 
A product of in vitro sensitized thymus-dependent c~lls. Eur. J. Immunol, 3:56-58. 
17  Lin, H.-S., and S. Gordon. 1979. Secretion  of plasrainogen  activator by bone marrow- 
derived mononuclear phagocytes and its enhancement by colony-stimulating  factor. J. 
£xp. M'ed. 150:231-235. 
18.  San, D., and M.  Lohmann-Matthes.  1982. Functionally  different  subpopulations  of 
mouse macrophages recognized  by mc~noelonal antibodies,  Eur, J. Immunol.  12:134- 
140, 
19.  gaffe. H+, L. Picker, and J. Stobo.  19,~O. M~crop/~ag¢ ~elerogene$1y in man: a subl~P- 
~lat~qn of ~LA-DR-bearing macrophages re~uired for antigen induced T ~elI activation 
contains stimulators for autologous-reaCltive T cerls..f Exp. MecL 152:581-593. 
20  Fallon, M, $. Teitelbaum, and A. Kahn. 19~3 Multinucleation  enhances macrophage- 
m~liatcd t~one resorption.  Lab. Invest. 49:159-164 
21  tgifkin, B., R. Baker, and S. Coleman. 1979~ An ultra.structural  study of macrophage- 
mediated resorption  of calcified tissue. Cell Tissue R¢5. 202:125-130. 
22  Ozdohy, P., M. Martini, and A. Caplan.  1982. Isolated  osteoclasts and their presumed 
progenitor cells, the monocyte, in culture.  Z Exp, Zool. 224:331-344. 
23.  Zambonin Zallone, A., and A, Teti. 1981. The osteoclasts of hen medullary bone under 
hypocalcemic conditions.  Anat Embryol,  162:379-392. 
24  Galfre. G,, S  Howe, C. Milstein, G. Butcher~ and I  Howard  1977 Antibodies to major 
histc~compatibility antigens produced by hybrid cell lines Nature (Lond.]. 266:550-552. 
25~  Shulman, M., C. Wilde, and G. Kohler. 1978. A 6otter cell line for making hybridomas 
secreting sOcclfic antibodies.  Nature (Land.). 276:269-270. 
26.  Osdohy,  p., and A. Caplan.  1979. Osteogenesis  in cultures of limb mesenchymal cells. 
Dev, Biol. 73:84-102. 
27.  Martini M., P. Osdoby,  and A. Caplan.  1982. Adhesion  of osteoclasts and monocytes 
to developing bone. J. Exp. Zoo/. 224:345-354. 
28.  Saint-Marie,  G.  1962. A paraffin  embedding technique for studies  employing immu- 
nofluorescence..L  Histochem.  Cytochem.  10:250-256. 
29.  Kennet, R. 1980. Enzyme-linkedantibodyassaywithcellsatlachedtopolyvinylchloride 
plates. In Monoclonal Antibodies  Hybridoma: A New Dimension in Biological Analysis. 
R, H  Kennet. editor.  Plenum Press, New York, 376-3~5. 
30.  Lowry, O, N, Rosenbroug,  A. Fan-, and R. Randall,  1951 Protein measurement with 
the folin phenol reagent../~ Biol. Chem.  193:265-275~ 
I  Laemmli, U. K. 1970. Cleavage of structural proteins during lhe assembly of the head 
of bacteriophage Tj. Nature (Land.). 227:681)-685 
32  ~nr~ette. W. i  98 I.  "Western Blotting, ~ E}ectro~l~c,  ret~c Lransfet ofptolmns from  sodium 
doclecyl sulfnte-polya¢,'3'Iam,/~e  ~o~s to u~rn~cii~ed nitrocelluic~¢ aa~ radiographic de- 
tection with atRibody and radioiodinated  protein A. Anal. B*~hem  I [ 2:1~)5-203. 
3].  Laodreth, K,, P, Kincade, G. Lee, W. Gathlings, and S. M  Fu,  1982. Enrichment of 
human  marrow lymphocytes with monoclonal antibodi~  to  murine antigens.  Proc. 
Natl  /Icad Sci.  USA. 79:2370-2374. 
34.  Ha~horn, $. 1929. Multinucleated  giant cells. Arch. PathoL 7:051-713. 
35.  Urist,  M.,  R.  Delaoge,  and G. Finerman.  1983. Bone cell differentiation  and growth 
factors, Science (Wash. DC). 220:680-685. 
36.  Malone, J., S. Teitelbaum, G. Griffin,  R. Senior.  and A. Kahn.  1982. Recruitment of 
osteoclast precursors  by purified  bone matrix constituents,  j, Cell Biol. 92:227-230. 
1600  THE JOURNAL OF CELL 81OLOCV .  VOLUME  I00, 1985 